氨酸上调1:在人类疾病的免疫细胞介导病原发生过程中的双调节剂
Xin Lan1, Shuwen Zhang1, Lu Yang2
1Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, 330000, Jiangxi, China.
Progress in biophysics and molecular biology
|July 17, 2025
概括
氨酸上调1 (TUG1),一种长非编码RNA,通过改变免疫细胞活性来影响疾病. 它促进非癌症疾病的炎症和癌症的免疫耐受性,影响疾病的进展.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 氨酸上调1 (TUG1) 是一种长非编码RNA (lncRNA),与各种疾病有关.
- TUG1调节免疫细胞活动,影响癌症和非癌症疾病的发病.
- 它的作用涉及竞争的内源RNA (ceRNA) 网络和转录因子调制.
研究的目的:
- 系统地评估不同疾病中异常TUG1表达的影响.
- 阐明TUG1在调节免疫细胞透和疾病进展方面的机制.
- 确定与TUG1的致病作用相关的潜在未来研究目标.
主要方法:
- 系统评估TUG1在各种疾病环境中的影响.
- 对TUG1对免疫细胞透的调节机制的分析.
- 审查TUG1在ceRNA网络和转录因子活性中的作用.
主要成果:
- 在非癌症疾病中,TUG1通过NF-κB等途径促进促炎性细胞因子,影响Th2细胞,M1巨细胞和微质细胞.
- 在癌症中,TUG1通过调节免疫检查点,促进前瘤细胞 (Tregs,M2巨细胞) 和抑制抗瘤细胞 (CD8+ T细胞,NK细胞) 来促进免疫耐受性.
- 异常的TUG1表达显著影响免疫细胞透和整体疾病进展.
结论:
- TUG1是癌症和非癌症疾病中免疫反应的关键调节者.
- 了解TUG1在炎症和免疫耐受性方面的双重作用是开发治疗策略的关键.
- 对TUG1机制的进一步研究可能会揭示免疫相关疾病的新型治疗点.
更多相关视频
相关概念视频
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
General Transcription Factors
5.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.6K
Transduction
120
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
120


